YSB Inc
Company Profile
Business description
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Group mainly engaged in i) wholesales of pharmaceutical and healthcare products offline or online through its online platform; ii) retail of pharmaceutical and healthcare products through its retail shops; iii) operating online platform that enable the pharmaceutical distributors and vendors to sell their own pharmaceutical and healthcare products using the Group’s online platform; iv) providing SaaS solution to downstream pharmacies to streamline their inventory management; and v) providing medical testing services to primary healthcare institutions. The Group principally operates in the PRC and generates the majority of its revenues from the PRC.
Contact
No. 8 Brand Street, No. 397 Xingang Middle Road
Yaoshibang Building
TIT Creative Industry Zone
Guangzhou
CHNT: +86 4001180958
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 December 2026
Employees
6,620
Stocks News & Analysis
stocks
Earnings Winners: BHP, NAB & TLS lead the pack
stocks
Walmart earnings: Growth in digital buoys margin amid consumer trade-down
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,303.20 | 9.30 | 0.10% |
| CAC 40 | 8,455.44 | 56.66 | 0.67% |
| DAX 40 | 25,096.98 | 53.41 | 0.21% |
| Dow JONES (US) | 49,395.16 | 267.50 | -0.54% |
| FTSE 100 | 10,672.57 | 45.53 | 0.43% |
| HKSE | 26,413.35 | 292.59 | -1.10% |
| NASDAQ | 22,682.73 | 70.91 | -0.31% |
| Nikkei 225 | 56,825.70 | 642.13 | -1.12% |
| NZX 50 Index | 13,308.52 | 135.68 | -1.01% |
| S&P 500 | 6,861.89 | 0.00 | 0.00% |
| S&P/ASX 200 | 9,081.40 | 17.00 | 0.19% |
| SSE Composite Index | 4,082.07 | 51.95 | -1.26% |